Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001140361-22-032970

10% owner sold 1,400,000 shares at an average $29.80 ($41,719,639)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −80,715 $27.28 $2,202,091 4,789,821 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −108,631 $28.16 $3,058,582 4,681,190 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −159,026 $29.14 $4,634,431 4,522,164 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −15,996 $30.59 $489,278 4,506,168 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −111,102 $32.23 $3,580,773 4,395,066 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −38,116 $27.28 $1,039,892 2,261,884 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −51,298 $28.16 $1,444,331 2,210,586 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −75,096 $29.14 $2,188,493 2,135,490 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −7,554 $30.59 $231,058 2,127,936 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-08 Sale −52,466 $32.23 $1,690,958 2,075,470 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-09 Sale −312,353 $29.87 $9,329,266 4,082,713 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-09 Sale −156,463 $30.90 $4,834,128 3,926,250 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-09 Sale −6,654 $31.44 $209,218 3,919,596 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-09 Sale −147,502 $29.87 $4,405,545 1,927,968 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-09 Sale −73,886 $30.90 $2,282,804 1,854,082 I
VIKING GLOBAL INVESTORS LP 10% owner 2022-09-09 Sale −3,142 $31.44 $98,792 1,850,940 I
Open-market sales · 1,400,000 sh · avg $29.80 · $41,719,639
Loading xslF345X03/form4.xml…